Antidepressant Effect of a Polyherbal Syrup Based on Iranian Traditional Medicine

Document Type: Original paper

Authors

1 Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Traditional Medicine and Materia Medica Research Center and Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

2 Traditional Medicine and Materia Medica Research Center and Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

3 Traditional Medicine and Materia Medica Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

Background and objectives: Depression is a common and costly public-health disease. It has been considered in Iranian traditional medicine and many herbal combinations have been used for healing depressive-like disorders. Traditional herbal medicines should be converted into common dosage forms for patient acceptance and easier usage. Methods: In the present research, a poly herbal syrup containing Echium amoenum, Lavandula angustifolia, Melissa officinalis, Cuscuta chinensis, Vitis sp., Prunus domestica and Alhagi camelorum was formulated and its physicochemical characteristics including physical appearance, pH, viscosity, density, dried residue, physical stability and microbiological levels were evaluated. Furthermore, the antidepressant activity was determined by tail suspension test (TST) and also the effect of the formulation on the serum levels of dopamine and adrenaline was assessed in mice. Results: The syrup showed to be stable regarding physical changes and microbiological quality control tests. It significantly reduced the time of immobility in TST (p<0.05) and increased the serum levels of dopamine (p<0.001) more considerable than the positive control group fluoxetine (p<0.01). Compared with the saline control group, the serum level of adrenaline in the syrup low dose (3 mL/kg) and fluoxetine groups increased but in high dose of the syrup (6 mL/kg) significantly decreased (p<0.05). Conclusion: Regarding the modern evidences about the plants used in the poly herbal syrup and physiochemical stability and the considerable results of the in vivo experiments, it could be suggested as a suitable antidepressant agent.
 

Keywords


[1] Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014; 4: 1-10.

[2] Butler L, Pilkington K. Chinese herbal medicine and depression: the research evidence. Evid Based Complement Alternat Med. 2013; Article ID 739716.

[3] Moein E, Hajimehdipoor H, Hamzeloo-Moghadam M, Choopani R, Toliyat T. Review of an aloe-based formulation used in Iranian traditional medicine. Jundishapur J Nat Pharm Prod. 2016; Article ID e40193.

[4] Rabiei Z, Rabiei S. A review on antidepressant effect of medicinal plants. Bangladesh J Pharmacol. 2017; 12(1): 1-11.

[5] Perviz S, Khan H, Pervaiz A. Plant alkaloids as an emerging therapeutic alternative for the treatment of depression. Front Pharmacol. 2016; 7: 1-7.

[6] Zarghami M, Chabra A, Azadbakht M, Khalilian A, Hoseini A. Antidepressant effect of Asperugo procumbens L. in comparison with fluoxetine: a randomized double blind clinical trial. Res J Pharmacogn. 2018; 5(3): 15-20.

[7] Nazem Jahan MA. Exir-e-azam. Tehran: Iran University of Medical Sciences, 2008.

[8] [7] Nazem Jahan MA. Qarabadin-e-Azam. Tehran: Research Institute for Islamic & Complementary Medicine, 2003.

[9] Arzani MA. Tebb-e-Akbari. Tehran: Institute of Medical History, Islamic and Complementary Medicine, Iran University of Medical Sciences, 2005.

[10] National Research Council. Guide for the care and use of laboratory animals. Washington D.C.: National Academies Press, 2010.

[11] Iranian Herbal Pharmacopoeia Committee. Iranian herbal pharmacopoeia. Tehran: Ministry of Health and Medical Education Publications, Food and Drug Administration, 2002.

[12] The British Pharmacopoeia Commission. British pharmacopoeia. London: The Stationary Office, 2011.

[13] Committee for the Unani Pharmacopoeia of India. Unani pharmacopoeia of India. New Delhi: Department of AYUSH, Ministry of Health & Family Welfare, 2007.

[14] World Health Organization. Quality control methods for medicinal plant materials. Geneva: WHO Press, 2011.

[15] Hamzeloo-Moghadam M, Danaifar N, Mostafavi SA, Hajimehdipoor H. Formulation and quality control of Prunus domestica syrup, prepared according to Iranian traditional medicine. Res J Pharmacogn. 2015; 2(2): 13-17.

[16] Halip A, Imam G, Yusup A. The effect of abnormal savda munziq (ASMq) on biological syndromes of depression animal models. [Accessed 2017]. Available fromhttp://en.cnki.com.cn/Article_en/CJFDTotal-XJYY201703034.htm.

[17] Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 2005; 29(4-5): 571-625.

[18] Mahmoudi E, Faizi M, Hajiaghaee R, Razmi A. Alteration of depressive-like behaviors by Psilocybe cubensis alkaloid extract in mice: the role of glutamate pathway. Res J Pharmacogn. 2018; 5(2): 17-24.

[19] Voiculescu S, Rosca A, Zeca V, Zagrean L, Zagrean A. Impact of maternal melatonin suppression on forced swim and tail suspension behavioral despair tests in adult offspring. J Med Life. 2015; 8(2): 202-206.

[20] Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacol. 1985; 85(3): 367-370.

[21] Sayyah M, Boostani H, Pakseresht S, Malaieri A. Efficacy of aqueous extract of Echium amoenum in treatment of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33(8): 1513-1516.

[22] Saki K, Bahmani M, Rafieian-Kopaei M. The effect of most important medicinal plants on two important psychiatric disorders (anxiety and depression) a review. Asian Pac J Trop Dis. 2014; 7(S1): 34-42.

[23] López V, Martín S, Gómez-Serranillos MP, Carretero ME, Jäger AK, Calvo MI. Neuroprotective and neurological properties of Melissa officinalis. Neurochem Res. 2009; 34(11): 1955-1961.

[24] Taiwo AE, Leite FB, Lucena GM, Barros M, Silveira D, Silva MV, Ferreira VM. Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: influence of administration and gender. Indian J Pharmacol. 2012; 44(2): 189-192.

[25] Mokhtarifar N, Sharif B, Naderi N, Mosaddegh M, Faizi M. Evaluation of anti-depressant effects of Cuscuta chinensis in experimental models. Res Pharm Sci. 2012; 7(5): 826.

[26] Firoozabadi A, Zarshenas MM, Salehi A, Jahanbin S, Mohagheghzadeh A. Effectiveness of Cuscuta planiflora Ten. and Nepeta menthoides Boiss. &Buhse in major depression: a triple-blind randomized controlled trial study. J Evid Based Complement Alternat Med. 2015; 20(2): 94-97.

[27] Cheng D, Murtaza G, Ma S, Li L, Li X, Tian F, Zheng J, Lu Y. In silico prediction of the anti-depression mechanism of a herbal formula (Tiansi liquid) containing Morinda officinalis and Cuscuta chinensis. Molecules. 2017; 22(10): 1-16.

[28] Aslam M, Sultana N. Vitis vinifera juice ameliorates depression-like behavior in mice by modulating biogenic amine neurotransmitters. Bangladesh J Pharmacol. 2015; 10(4): 753-758.

[29] Solanki N, Alkadhi I, Atrooz F, Patki G, Salim S. Grape powder prevents cognitive, behavioral, and biochemical impairments in a rat model of posttraumatic stress disorder. Nutr Res. 2015; 35(1): 65-75.

[30] Tavakkoli-Kakhki M, Motavasselian M, Mosaddegh M, Esfahani MM, Kamalinejad MM, Nematy M. Food-based strategies for depression management from Iranian traditional medicine resources. Iran Red Crescent Med J. 2014; 16(2): 1-5.

[31] Yousofpour M, Kamalinejad M, Esfahani MM, Iran-nejad S, Shorofi SA, Shams J. Non-pharmacological interventions for depression in Persian medicine. Tang. 2015; 5(4): 1-7.

[32] Thakare VN, Patil RR, Oswal RJ, Dhakane VD, Aswar MK, Patel BM. Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice. J Psychopharmacol. 2018; 32(2): 223-235.

[33] Hong LZ, Huang KF, Hung SW, Kuo LT. Chronic fluoxetine treatment enhances sympathetic activities associated with abnormality of baroreflex function in conscious normal rats. Eur J Pharmacol. 2017; 811: 164-170.

[34] Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry. 2004; 6(4): 159-166.